Information about Camba-Pharma
My details
*
*
*

Camba-Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0717.740.414

VAT liability
Yes
Established
07-01-2019
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Camba-Pharma

2024 2023 2022 2021
Profit/Loss 36,955 15 % 32,054 1 % 31,841 57 % 20,240
Equity 104,449 55 % 67,494 34 % 50,441 -16 % 59,833
Gross margin 57,060 16 % 49,374 -2 % 50,436 52 % 33,234

Publications from Camba-Pharma

Date Publication
29-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
03-01-2023 Registered Office - Modification Legal Form (NL)
24-01-2020 Registered Office (NL)
09-01-2019 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Camba-Pharma?
The VAT number of Camba-Pharma is BE 0717.740.414.
Wat is the PEPPOL ID of Camba-Pharma?
The PEPPOL ID of Camba-Pharma is 0208:0717740414. Log in or start a free trial to see the full overview.
When was Camba-Pharma founded?
Camba-Pharma was founded on 07-01-2019.
What is the address of Camba-Pharma?
The current registered office of Camba-Pharma is located at Droogveldeweg 7, 9031 Gent.
When was the last time Camba-Pharma filed their annual financial statements?
The most recent financial statements of Camba-Pharma were filed on 22-07-2025.
How many employees does Camba-Pharma have?
There are currently no employees working at Camba-Pharma or no workforce information is available.
What is the annual turnover of Camba-Pharma?
At the time of its most recent financial statements, Camba-Pharma did not publish any turnover figures. Camba-Pharma reported a gross margin of €57,059.69.